1.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: Over 55
Sponsor: Other
Protocol IDs: GMALL02, NCT00198978
|
|
2.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL01, NCT00198991
|
|
3.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL03, NCT00199004
|
|
4.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: Over 15
Sponsor: Other
Protocol IDs: GMALL05, NCT00199082
|
|
5.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 65 and under
Sponsor: Other
Protocol IDs: LAL-Ph-2000, NCT00526305
|
|
6.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL04, NCT00199017
|
|
7.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 16 and over
Sponsor: Other
Protocol IDs: LAL-AR/2003, NCT00853008
|
|
8.
|
Phase: Phase III
Type: Diagnostic, Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: PETAL trial, EudraCT-Number 2006-001641-33, Krebshilfe Grant 107592, NCT00554164
|
|
9.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 55
Sponsor: Other
Protocol IDs: 9L-03-1, NCT00184041
|
|
10.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and under
Sponsor: Other
Protocol IDs: ALLR17, NCT00186875
|
|
11.
|
Phase: No phase specified
Type: Treatment
Status: Active
Age: 1 to 18
Sponsor: Other
Protocol IDs: GER-COALL-07-03, EU-205104, NCT00343369
|
